Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection. uri icon

Overview

abstract

  • Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.

publication date

  • August 10, 2020

Identity

PubMed Central ID

  • PMC8511378

Scopus Document Identifier

  • 85101396055

Digital Object Identifier (DOI)

  • 10.3947/ic.2020.0204

PubMed ID

  • 32869551

Additional Document Info

volume

  • 53

issue

  • 3